INTELLIA THERAPEUTICS, INC. (NTLA) Shareholders’ equity 2016–2025
INTELLIA THERAPEUTICS, INC. (NTLA) shareholders’ equity at each fiscal year-end, per SEC filings.
$671.4MFY2025 · since FY2016: $209.8M → $671.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $671.4M | -23.0% |
| FY2024 | $872.0M | -17.0% |
| FY2023 | $1.1B | -15.0% |
| FY2022 | $1.2B | +18.8% |
| FY2021 | $1.0B | +97.4% |
| FY2020 | $527.1M | +95.3% |
| FY2019 | $269.9M | -2.9% |
| FY2018 | $277.9M | -7.5% |
| FY2017 | $300.6M | +43.3% |
| FY2016 | $209.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice